Header

UZH-Logo

Maintenance Infos

Publications for Taffé, P

Navigate back| Up a level
Export as
Group by:
Number of items: 15.

2018

Bibert, Stéphanie; Wojtowicz, Agnieszka; Taffé, Patrick; Tarr, Philip E; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Hoffmann, Matthias; Kaiser, Laurent; Osthoff, Michael; Fellay, Jacques; Cavassini, Matthias; Bochud, Pierre-Yves; Swiss HIV Cohort Study (2018). IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma. AIDS, 32(18):2759-2765.

2015

Fournier, Stephane; Taffé, Patrick; Radovanovic, Dragana; Von Elm, Erik; Morawiec, Beata; Stauffer, Jean-Christophe; Erne, Paul; Beggah, Ahmed; Monney, Pierre; Pascale, Patrizio; Iglesias, Juan-Fernando; Eeckhout, Eric; Muller, Olivier (2015). Myocardial infarct size and mortality depend on the time of day-a large multicenter study. PLoS ONE, 10(3):e0119157.

2014

Bibert, Stéphanie; Wojtowicz, Agnieszka; Taffé, Patrick; Manuel, Oriol; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Hoffmann, Matthias; Kaiser, Laurent; Osthoff, Michael; Cavassini, Matthias; Bochud, Pierre-Yves (2014). The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. AIDS, 28(13):1885-1889.

Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; Yerly, Sabine; Shah, Cyril; Aubert, Vincent; Klimkait, Thomas; Taffé, Patrick; Furrer, Hansjakob; Battegay, Manuel; Ambrosioni, Juan; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro L; Ledergerber, Bruno; Günthard, Huldrych F; Kouyos, Roger D (2014). Treatment-Naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Clinical Infectious Diseases, 58(2):285-294.

2013

Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, H; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Schmid, P; Schultze, D; Schöni-Affolter, F; Schüpbach, J; Speck, R; Taffé, P; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S (2013). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine, 14(4):195-207.

2011

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Rieder, P; Joos, B; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Rauch, A; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, 52(4):532-539.

2010

Rotger, M; Gsponer, T; Martinez, R; Taffé, P; Elzi, L; Vernazza, P; Cavassini, M; Bernasconi, E; Hirschel, B; Furrer, H; Weber, R; Ledergerber, B; Egger, M; Telenti, A; Tarr, P E; Swiss HIV Cohort Study (2010). Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals. Clinical Infectious Diseases, 51(9):1090-1098.

Hauser, P M; Nahimana, A; Taffé, P; Weber, R; Francioli, P; Bille, J; Rabodonirina, M (2010). Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clinical Infectious Diseases, 51(4):e28-e33.

Audigé, A; Taffé, P; Rickenbach, M; Battegay, M; Vernazza, P; Nadal, D; Speck, R (2010). Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors. AIDS Research and Human Retroviruses, 26(9):997-1005.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Furrer, H; Battegay, M; Vernazza, P L; Bernasconi, E; Rickenbach, M; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2010). Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. Journal of Infectious Diseases, 201(10):1488-1497.

Osih, R B; Taffé, P; Rickenbach, M; Gayet-Ageron, A; Elzi, L; Fux, C; Opravil, M; Bernasconi, E; Schmid, P; Günthard, H F; Cavassini, M (2010). Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study. AIDS Research and Human Retroviruses, 26(11):1239-1246.

2009

Rotger, M; Bayard, C; Taffé, P; Martinez, R; Cavassini, M; Bernasconi, E; Battegay, M; Hirschel, B; Furrer, H; Witteck, A; Weber, R; Ledergerber, B; Telenti, A; Tarr, P E (2009). Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation: Cardiovascular Genetics, 2(6):621-628.

2007

Bochud, Pierre-Yves; Hersberger, Martin; Taffé, Patrick; Bochud, Murielle; Stein, Catherine M; Rodrigues, Stephanie D; Calandra, Thierry; Francioli, Patrick; Telenti, Amalio; Speck, Roberto F; Aderem, Alan (2007). Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS, 21(4):441-446.

2005

Rotger, Margalida; Taffé, Patrick; Bleiber, Gabriela; Günthard, Huldrych F; Furrer, Hansjakob; Vernazza, Pietro; Drechsler, Henning; Bernasconi, Enos; Rickenbach, Martin; Telenti, Amalio (2005). Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia. Journal of Infectious Diseases, 192(8):1381-1386.

Tarr, Philip E; Taffé, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; Rotger, Margalida; Martinez, Raquel; Hirschel, Bernard; Battegay, Manuel; Weber, Rainer; Vernazza, Pietro; Bernasconi, Enos; Darioli, Roger; Rickenbach, Martin; Ledergerber, Bruno; Telenti, Amalio (2005). Modeling the Influence ofAPOC3, APOE,andTNFPolymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid Disorders. Journal of Infectious Diseases, 191(9):1419-1426.

This list was generated on Tue Apr 23 10:11:41 2019 CEST.